Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125292661 | 12529266 | 1 | I | 20151111 | 20160628 | 20160705 | 20160705 | EXP | ES-AGEMED-810670344 | ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-42497ES | BOEHRINGER INGELHEIM | 81.00 | YR | F | Y | 0.00000 | 20160706 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125292661 | 12529266 | 1 | PS | MICARDISPLUS | HYDROCHLOROTHIAZIDETELMISARTAN | 1 | Oral | 80 MG | Y | 21162 | 80 | MG | TABLET | QD | |||||
| 125292661 | 12529266 | 2 | SS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 15 MG | Y | 0 | 15 | MG | QD | ||||||
| 125292661 | 12529266 | 3 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG | Y | 0 | 50 | MG | QD | ||||||
| 125292661 | 12529266 | 4 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Unknown | 4 MG | 0 | 4 | MG | QD | |||||||
| 125292661 | 12529266 | 5 | C | SUMIAL | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 60 MG | 0 | 20 | MG | TID | |||||||
| 125292661 | 12529266 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 20 MG | 0 | 20 | MG | QD | |||||||
| 125292661 | 12529266 | 7 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 10 MG | 0 | 5 | MG | BID | |||||||
| 125292661 | 12529266 | 8 | C | SINEMET PLUS | CARBIDOPALEVODOPA | 1 | Unknown | 0 | QID | ||||||||||
| 125292661 | 12529266 | 9 | C | AZILECT | RASAGILINE MESYLATE | 1 | Unknown | 1 MG | 0 | 1 | MG | QD | |||||||
| 125292661 | 12529266 | 10 | C | EXELON | RIVASTIGMINE TARTRATE | 1 | Unknown | 9.5 MG | 0 | 9.5 | MG | QD | |||||||
| 125292661 | 12529266 | 11 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG | 0 | 75 | MG | QD | |||||||
| 125292661 | 12529266 | 12 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 25 MG | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125292661 | 12529266 | 1 | Hypertension |
| 125292661 | 12529266 | 2 | Product used for unknown indication |
| 125292661 | 12529266 | 3 | Depression |
| 125292661 | 12529266 | 4 | Product used for unknown indication |
| 125292661 | 12529266 | 5 | Product used for unknown indication |
| 125292661 | 12529266 | 6 | Product used for unknown indication |
| 125292661 | 12529266 | 7 | Product used for unknown indication |
| 125292661 | 12529266 | 8 | Product used for unknown indication |
| 125292661 | 12529266 | 9 | Product used for unknown indication |
| 125292661 | 12529266 | 10 | Product used for unknown indication |
| 125292661 | 12529266 | 11 | Product used for unknown indication |
| 125292661 | 12529266 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125292661 | 12529266 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125292661 | 12529266 | Drug interaction | |
| 125292661 | 12529266 | Inappropriate antidiuretic hormone secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125292661 | 12529266 | 1 | 201508 | 20151111 | 0 | |
| 125292661 | 12529266 | 2 | 201508 | 20151111 | 0 | |
| 125292661 | 12529266 | 3 | 20151027 | 20151111 | 0 |